BGLC — BioNexus Gene Lab Corp

—
Nasdaq · Health Care · Health Care Providers & Services · CIK 1737523 · Malaysia
Last close
$0.77
Market Cap
$2.25M
52W High
$4.97
52W Low
$0.66
ADV30
6,651
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 76,156 12,982 -312,018 -286,451 8,726,423 1,232,658 947,981
Mar 2026 22,842 -790 -571,433 -543,575 9,040,130 1,337,554 946,877
Dec 2025 483,760 -3,983 -1,032,000 -1,036,117 9,252,784 2,383,369 637,856
Sep 2025 2,543,823 377,685 -810,269 -708,991 7,621,228 1,153,121 804,966

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-846,565
Investing CF
$1,391,081
Financing CF
$374,047
CapEx
$-7,035
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.08
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-7,257,253
Inventory
$652,892
Receivables
$185,654
ST Investments
$2,288,874
EBIT TTM
$-2,558,240
Pretax Income TTM
$-2,575,134
Interest Exp TTM
$16,894
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,126,581
EBITDA
$-2,640,000
Free Cash Flow
$68,315
Enterprise Value
$1,524,506
Total Cash
$3,521,532
Total Debt
$323,197
Shares Out
2,933,442
Trailing EPS
$-1.26
Book Value
$3.22
ROE
-33.7%
ROA
-19.0%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 7,424,911 -3,158,450 -2,984,607 9,252,784 637,856 8,614,928 -1,838,382
Dec 2024 9,510,646 -1,956,763 -1,598,342 10,433,848 2,111,044 8,322,804 -2,093,260
Dec 2023 9,770,806 -3,079,624 -2,629,043 11,399,793 1,741,941 9,657,852 -1,822,212
Dec 2022 10,928,707 -291,177 -355,966 8,740,162 2,075,149 6,665,013 551,822

TTM Snapshot

Revenues TTM
$3,126,581
NetIncome TTM
$-2,575,134
OpCashFlow TTM
—
Assets (Latest)
$8,726,423
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
HLYK HealthLynked Corp $2.51M $0.85 —
BRTX BioRestorative Therapies, Inc. $1.85M $1.34 —
MGRX MANGOCEUTICALS, INC. $3.45M $0.16 —
ADVB Advanced Biomed Inc. $3.47M $2.10 —
ACON Aclarion, Inc. $3.95M $1.37 —

News headlines (Yahoo Finance, 1h cache)

BioNexus Launches BGLC 1Lab Pilot for GeneMatrix Workflows at MRNA Scientific
2026-11-03 14:00 · Yahoo
BioNexus Launches New Corporate Website with Expanded Business and Investor Resources
2026-10-30 13:00 · Yahoo
BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence
2026-10-07 12:30 · Yahoo
RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab
2026-10-05 13:00 · Yahoo
BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit
2026-07-28 13:00 · Yahoo
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
2026-05-29 13:00 · Yahoo
BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
2026-03-11 12:45 · Yahoo
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
2026-02-23 13:30 · Yahoo
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
2026-01-28 14:00 · Yahoo
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
2025-12-01 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.